Published in Bone Marrow Transplant on November 01, 1989
The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med (2013) 1.00
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. Bone Marrow Transplant (2012) 0.91
Biotechnology in the treatment of sensorineural hearing loss: foundations and future of hair cell regeneration. J Speech Lang Hear Res (2011) 0.85
Quantifying adhesion mechanisms and dynamics of human hematopoietic stem and progenitor cells. Sci Rep (2015) 0.79
A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. Korean J Intern Med (1998) 0.77
Supportive care in patients with acute leukaemia: historical perspectives. Blood Transfus (2014) 0.76
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med (1984) 15.06
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol (1998) 4.92
ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials (2001) 4.27
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20
Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect Immun (1974) 4.19
Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children. BMJ (1998) 4.14
Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura. Lancet (1997) 4.09
Some characteristics of homosexual men. Br J Vener Dis (1976) 4.00
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52
Conformational change in the DNA associated with an unusual promoter mutation in a tRNA operon of Salmonella. Cell (1984) 3.44
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (1998) 3.21
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood (1999) 2.95
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A (2003) 2.95
Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol (1987) 2.81
Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst (2001) 2.62
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem (2001) 2.58
Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev (2000) 2.52
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology (1990) 2.40
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Macromolecular synthesis in Bacillus subtilis during development of the competent state. J Bacteriol (1971) 2.35
Mantle cell lymphoma-- an entity comes of age. Blood (1996) 2.30
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (2002) 2.28
Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann Occup Hyg (1987) 2.23
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control (1994) 2.07
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol (1975) 2.05
Epithelial-mesenchymal signaling during the regionalization of the chick gut. Development (1998) 2.05
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol (1995) 2.02
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J Clin Oncol (1993) 2.00
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med (1987) 1.98
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell (1998) 1.95
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. J Clin Oncol (1991) 1.94
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Incidence and mutation rates of structural rearrangements of the autosomes in man. Ann Hum Genet (1972) 1.86
Encouraging primary care physicians to help smokers quit. A randomized, controlled trial. Ann Intern Med (1989) 1.86
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology (2009) 1.83
Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol (1985) 1.79
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol (1993) 1.79
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res (1985) 1.78
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD. Mol Psychiatry (2012) 1.75
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70
Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup Environ Med (2003) 1.70
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol (1993) 1.69
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol (1993) 1.66
The inheritance of translocations in man: data from families ascertained through a balanced heterozygote. Ann Hum Genet (1970) 1.66
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer (1981) 1.65
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J (2006) 1.64
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med (1989) 1.62
The loss of bone mineral with aging and its relationship to risk of fracture. J Clin Invest (1975) 1.61
Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma. Scand J Work Environ Health (1993) 1.61
Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology (1996) 1.60
Isolation of large numbers of fully viable human neutrophils: a preparative technique using percoll density gradient centrifugation. Exp Hematol (1982) 1.59
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.58
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood (1987) 1.56
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma (2007) 1.54
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol (1996) 1.53
The social work externship. J R Coll Gen Pract (1973) 1.53
Counseling medical and dental patients about cigarette smoking: the impact of nicotine gum and chart reminders. Am J Public Health (1987) 1.53
Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care (2001) 1.52
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
Is more better? Dose intensity in neuroblastoma. J Clin Oncol (1991) 1.51
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol (1993) 1.49
Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health (1992) 1.48
Clinical applications of hematopoietic growth factors. J Clin Oncol (1995) 1.47
Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer (1996) 1.47
In vivo measurement of bone mass in the radius. Metabolism (1968) 1.46
Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med (1997) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab (1979) 1.45
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci U S A (1995) 1.45
Toward common ground. Diabetes Care (1997) 1.43
Servo control of end-tidal CO2 in paralyzed animals. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.42
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood (1986) 1.42